b12 injection with tirzepatide + – 2ML – 34MG Tirzepatide, Glycine + Vitamin B12

doi:10.11604/pamj.2021.38.237.20967

This solution is designed for intramuscular or intravenous injection, typically administered using a syringe

At the enzymatic level, AOD 9604 has been shown to promote triglyceride hydrolysis while inhibiting lipogenesis through modulation of acetyl-CoA carboxylase activity

injection is a shot given in large muscle groups, typically shoulder (deltoid), thigh (vastus lateralis) and/or butt (gluteus)

Specifications Strength 5 mg/vial Form Lyophilized powder Presentation Single-dose sterile vial Purity 98% by HPLC Testing Identity, potency, sterility Storage Refrigerate, protect from light Release Certificate of analysis per lot Prescribing information How AOD-9604 is supplied

This distinction is crucial for appropriate clinical investigation and management